Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 02, 2021

SELL
$1.22 - $2.0 $278 - $456
-228 Closed
0 $0
Q2 2021

Aug 02, 2021

SELL
$1.35 - $3.36 $29,797 - $74,161
-22,072 Reduced 98.98%
228 $0
Q2 2019

Aug 09, 2019

SELL
$8.77 - $12.49 $14,909 - $21,233
-1,700 Reduced 7.08%
22,300 $222,000
Q2 2018

Aug 10, 2018

BUY
$8.75 - $23.27 $210,000 - $558,480
24,000 New
24,000 $410,000

About Eloxx Pharmaceuticals, Inc.


  • Ticker ELOX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,656,200
  • Description
  • Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis p...
More about ELOX
Track This Portfolio

Track New York State Common Retirement Fund Portfolio

Follow New York State Common Retirement Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.